We strive to optimize the benefits of GLP-1 medications, including their potential cardiovascular advantages, to enhance the overall well-being of our patients
At Boca Medical Care, we are committed to assisting you on your wellness journey
But its the exception, not the rule, Kim said
First-line therapy Offer metformin modified-release (M/R) and SGLT2 inhibitor dual therapy first-line, even if no other comorbidity is present, unless contraindicated (caution with SGLT2is in those with frailty)
Both products will be available to employers in January 2025.
And none of the big GLP-1 trials studied anything like microdosing. So right away, if youre going off-label, youre stepping into the unknown. Heres a quick rundown of what might drive someone to try a less-is-more approach: Cost concerns: Depending on your insurance (or lack thereof), these medications can be pricy